PRICE T ROWE ASSOCIATES INC /MD/
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$538,507
-$34,796 QoQ
Shares Held
115,808
+8.7% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. AVIR ranks #205 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,507 | 115,808 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $573,303 | 106,562 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $347,432 | 97,320 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $282,845 | 97,533 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $287,676 | 79,910 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $238,930 | 79,910 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $247,508 | 73,883 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $234,503 | 70,001 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $220,644 | 66,660 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $271,233 | 67,137 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $168,265 | 55,169 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $126,726 | 42,242 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $154,207 | 41,232 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $133,142 | 39,744 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $138,590 | 28,813 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $157,163 | 27,621 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $163,875 | 23,081 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,219,831 | 445,960 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,691,460 | 412,915 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $52,448,532 | 1,495,965 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $36,333,033 | 1,691,482 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $158,164,906 | 2,561,375 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $105,201,079 | 2,517,977 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||